Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9164586rdf:typepubmed:Citationlld:pubmed
pubmed-article:9164586lifeskim:mentionsumls-concept:C0379900lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C1533157lld:lifeskim
pubmed-article:9164586lifeskim:mentionsumls-concept:C0254672lld:lifeskim
pubmed-article:9164586pubmed:issue1-2lld:pubmed
pubmed-article:9164586pubmed:dateCreated1997-7-30lld:pubmed
pubmed-article:9164586pubmed:abstractTextThe present experiments examined the ability of the novel 5-HT1A receptor antagonist to block responses mediated by postsynaptic and presynaptic 5-HT1A receptors in vivo. Pretreatment with p-MPPI reduced or blocked the effect of the 5-HT1A receptor agonist 8-OH-DPAT on two responses mediated by postsynaptic 5-HT1A receptors, reduction of body temperature and the 5-HT behavioral syndrome. Administration of p-MPPI alone did not alter body temperature or produce symptoms of the 5-HT syndrome. Pretreatment with p-MPPI also blocked the ability of 8-OH-DPAT to reduce extracellular 5-HT in the striatum, a response mediated by presynaptic 5-HT1A receptors in the dorsal raphe nucleus, but did not alter striatal 5-HT when administered alone. These results indicate that p-MPPI is an effective 5-HT1A receptor antagonist in vivo with no intrinsic activity. p-MPPI may prove to be a useful pharmacological tool for studying 5-HT1A receptors and their involvement in anxiety and affective disorders.lld:pubmed
pubmed-article:9164586pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:languageenglld:pubmed
pubmed-article:9164586pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:citationSubsetIMlld:pubmed
pubmed-article:9164586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9164586pubmed:statusMEDLINElld:pubmed
pubmed-article:9164586pubmed:issn0091-3057lld:pubmed
pubmed-article:9164586pubmed:authorpubmed-author:SinghAAlld:pubmed
pubmed-article:9164586pubmed:authorpubmed-author:AllenA RARlld:pubmed
pubmed-article:9164586pubmed:authorpubmed-author:MARSP HPHlld:pubmed
pubmed-article:9164586pubmed:authorpubmed-author:KunsM DMDlld:pubmed
pubmed-article:9164586pubmed:authorpubmed-author:LuckiIIlld:pubmed
pubmed-article:9164586pubmed:authorpubmed-author:ZhuangZ PZPlld:pubmed
pubmed-article:9164586pubmed:issnTypePrintlld:pubmed
pubmed-article:9164586pubmed:volume57lld:pubmed
pubmed-article:9164586pubmed:ownerNLMlld:pubmed
pubmed-article:9164586pubmed:authorsCompleteYlld:pubmed
pubmed-article:9164586pubmed:pagination301-7lld:pubmed
pubmed-article:9164586pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:meshHeadingpubmed-meshheading:9164586-...lld:pubmed
pubmed-article:9164586pubmed:articleTitleThe 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors.lld:pubmed
pubmed-article:9164586pubmed:affiliationDepartment of Psychiatry, University of Pennsylvania, Philadelphia 19104-2649, USA.lld:pubmed
pubmed-article:9164586pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9164586pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9164586pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed